➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
AstraZeneca
Moodys
Boehringer Ingelheim
McKinsey

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

GLUCAGON - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for glucagon and what is the scope of freedom to operate?

Glucagon is the generic ingredient in five branded drugs marketed by Lilly, Eli Lilly And Co, Xeris, Novo Nordisk, and Fresenius Kabi Usa, and is included in six NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Glucagon has fifty-eight patent family members in thirty-one countries.

There are twelve drug master file entries for glucagon. One supplier is listed for this compound.

Drug Prices for GLUCAGON

See drug prices for GLUCAGON

Recent Clinical Trials for GLUCAGON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Translational Research Institute for Metabolism and Diabetes, FloridaPhase 2
Adrian VellaPhase 3
Steno Diabetes Center CopenhagenPhase 2

See all GLUCAGON clinical trials

Medical Subject Heading (MeSH) Categories for GLUCAGON

US Patents and Regulatory Information for GLUCAGON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eli Lilly And Co BAQSIMI glucagon POWDER;NASAL 210134-001 Jul 24, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-004 Sep 10, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Eli Lilly And Co BAQSIMI glucagon POWDER;NASAL 210134-001 Jul 24, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-004 Sep 10, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Dow
Merck
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.